MODULE 7: TARGET PRODUCT PROFILES
Pharmaceutical Preparations: fifty-first report (2), Target product profile – paediatric HIV (3), Lopez et al. (4) and Annex 2, Stability testing of active pharmaceutical ingredients and finished pharmaceutical products (5).
Download MODULE 7: TARGET PRODUCT PROFILES
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Can I receive workers’ compensation benefits if I get ...
www.wcb.ny.govhave a medical report, from an authorized workers’ compensation medical provider, stating that your work caused your illness. A positive test result is best, but a medical report, from an authorized workers’ compensation medical provider, showing a diagnosis via PCR test, or by virtue of an examination by a treating physician, may be used.
2020 - WHO
apps.who.intWorld Health Statistics 2020 sheds light on the progress towards relevant SDGs and their implications in the midst of the current COVID-19 emergency. The report highlights the need to track population health and its determinants in a comprehensive and continuous manner. This report’s key messages are presented below. 1.
Global tuberculosis report 2020: executive summary
apps.who.intGLOBAL TUBERCULOSIS REPORT 2020 3 Executive Summary Background Tuberculosis (TB) is a communicable disease that is a major cause of ill health, one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent (ranking above HIV/AIDS). TB is caused by the bacillus Mycobacterium tuberculosis, which is
GHANA Annual Report 2019 - World Health Organization
www.afro.who.intresults as at January 2020 showed marked increase of 26% in the case detection rates for tuberculosis across the country compared with January 2019. The National AIDS control program has been supported by organizing monthly update calls where programmatic data and performance is reviewed and required technical support
RESPIRATORY CONDITIONS (OTHER THAN …
www.benefits.va.govMar 31, 2020 · Respiratory Conditions Disability Benefits Questionnaire Updated on: March 31, 2020 ~v20_1 Released January 2022. RESPIRATORY CONDITIONS (OTHER THAN TUBERCULOSIS AND SLEEP APNEA) DISABILITY BENEFITS QUESTIONNAIRE. NAME OF PATIENT/VETERAN. PATIENT/VETERAN'S SOCIAL SECURITY NUMBER
GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED …
www.cdc.govThis report updates, expands, and replaces the previously published CDC "Guideline for Prevention of Nosocomial Pneumonia”. The new guidelines are designed to reduce the incidence of health-care-associated pneumonia and other severe, acute lower respiratory tract infections in
Latent Tuberculosis Infection: A Guide for Primary Health ...
www.cdc.govDivision of Tuberculosis Elimination Atlanta, Georgia 2020 2. TABLE OF CONTENTS 4 List of Abbreviations 5 Introduction 6 Targeted Testing for Tuberculosis 8 Diagnosis of Latent TB Infection (LTBI) Appendix A 36 Sample TB Risk Assessment Tool ... Weekly Report. NTCA. National Tuberculosis
The Global Impact of Respiratory Disease
www.who.intFIRS is contributing with this excellent report to put lung health high on the global agenda. I would like to congratulate FIRS for having prepared this very impressive comprehensive report on the global impact of tuberculosis, asthma, COPD, acute lower respiratory tract infections and lung cancer. It summarises in a very concise way